Drug resistance is a major obstacle in cancer treatment -- leading to relapse for many patients. In a new study, researchers report on a promising new strategy to overcome drug resistance in leukemia, using targeted doses of the widely-used chemotherapy drug doxorubicin.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/04/200420165730.htm
No comments:
Post a Comment